Cargando…

Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls

The genetic rat models such as rats of the WAG/Rij strain and GAERS were developed as models for generalized genetic epilepsy and in particular for childhood absence epilepsy. These animal models were described in the eighties of the previous century and both models have, among others, face, constru...

Descripción completa

Detalles Bibliográficos
Autores principales: van Luijtelaar, Gilles, van Oijen, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175742/
https://www.ncbi.nlm.nih.gov/pubmed/32351383
http://dx.doi.org/10.3389/fphar.2020.00395
_version_ 1783524891920695296
author van Luijtelaar, Gilles
van Oijen, Gerard
author_facet van Luijtelaar, Gilles
van Oijen, Gerard
author_sort van Luijtelaar, Gilles
collection PubMed
description The genetic rat models such as rats of the WAG/Rij strain and GAERS were developed as models for generalized genetic epilepsy and in particular for childhood absence epilepsy. These animal models were described in the eighties of the previous century and both models have, among others, face, construct and predictive validity. Both models were and are currently used as models to predict the action of antiepileptic medication and other experimental treatments, to elucidate neurobiological mechanisms of spike-wave discharges and epileptogenesis. Although the electroencephalagram (EEG)/electrocorticogram (ECoG) is imperative for establishing absence seizures and to quantify the for absence epilepsy typical spike-wave discharges, monitoring the animals behavior is equally necessary. Here an overview is given regarding the design of drug evaluation studies, which animals to use, classical and new EEG variables, the monitoring and quantification of the behavior of the rats, some pitfalls regarding the interpretation of the data, and some developments in EEG technology.
format Online
Article
Text
id pubmed-7175742
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71757422020-04-29 Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls van Luijtelaar, Gilles van Oijen, Gerard Front Pharmacol Pharmacology The genetic rat models such as rats of the WAG/Rij strain and GAERS were developed as models for generalized genetic epilepsy and in particular for childhood absence epilepsy. These animal models were described in the eighties of the previous century and both models have, among others, face, construct and predictive validity. Both models were and are currently used as models to predict the action of antiepileptic medication and other experimental treatments, to elucidate neurobiological mechanisms of spike-wave discharges and epileptogenesis. Although the electroencephalagram (EEG)/electrocorticogram (ECoG) is imperative for establishing absence seizures and to quantify the for absence epilepsy typical spike-wave discharges, monitoring the animals behavior is equally necessary. Here an overview is given regarding the design of drug evaluation studies, which animals to use, classical and new EEG variables, the monitoring and quantification of the behavior of the rats, some pitfalls regarding the interpretation of the data, and some developments in EEG technology. Frontiers Media S.A. 2020-04-14 /pmc/articles/PMC7175742/ /pubmed/32351383 http://dx.doi.org/10.3389/fphar.2020.00395 Text en Copyright © 2020 van Luijtelaar and van Oijen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
van Luijtelaar, Gilles
van Oijen, Gerard
Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title_full Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title_fullStr Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title_full_unstemmed Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title_short Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls
title_sort establishing drug effects on electrocorticographic activity in a genetic absence epilepsy model: advances and pitfalls
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175742/
https://www.ncbi.nlm.nih.gov/pubmed/32351383
http://dx.doi.org/10.3389/fphar.2020.00395
work_keys_str_mv AT vanluijtelaargilles establishingdrugeffectsonelectrocorticographicactivityinageneticabsenceepilepsymodeladvancesandpitfalls
AT vanoijengerard establishingdrugeffectsonelectrocorticographicactivityinageneticabsenceepilepsymodeladvancesandpitfalls